KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Fulgent Genetics (FLGT) FCF Margin (2016 - 2025)

Fulgent Genetics (FLGT) has disclosed FCF Margin for 11 consecutive years, with 20780.75% as the latest value for Q4 2025.

  • Quarterly FCF Margin fell 2080862.0% to 20780.75% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 51.81% through Dec 2025, down 4502.0% year-over-year, with the annual reading at 38.49% for FY2025, 3170.0% down from the prior year.
  • FCF Margin hit 20780.75% in Q4 2025 for Fulgent Genetics, down from 4.65% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 65.3% in Q3 2021 to a low of 20780.75% in Q4 2025.
  • Historically, FCF Margin has averaged 1082.9% across 5 years, with a median of 6.28% in 2022.
  • Biggest five-year swings in FCF Margin: surged 7555bps in 2021 and later plummeted -2080862bps in 2025.
  • Year by year, FCF Margin stood at 28.25% in 2021, then plummeted by -49bps to 14.52% in 2022, then increased by 16bps to 16.77% in 2023, then soared by 66bps to 27.87% in 2024, then plummeted by -74666bps to 20780.75% in 2025.
  • Business Quant data shows FCF Margin for FLGT at 20780.75% in Q4 2025, 4.65% in Q3 2025, and 34.27% in Q2 2025.